Patents by Inventor Glenn Steele

Glenn Steele has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Marker for colorectal carcinoma and methods of detecting the same
    Patent number: 4996298
    Abstract: A new marker for colorectal carcinoma has been discovered which is a goycoprotein having a molecular weight of approximately 160,000 daltons. Assay methods which can identify this marker are useful in detecting, diagnosing, and monitoring colorectal carcinoma, and in particular, carcinoma of the undifferentiated variety which heretofor were not readily detectible. For example, an assay which utilizes an antibody reacting to this glycoprotein marker is useful in a screening method for the detection and monitoring of colorectal carcinoma cells. Such an antibody can be included as part of a kit for screening a patient for colorectal carcinoma.
    Type: Grant
    Filed: January 22, 1990
    Date of Patent: February 26, 1991
    Assignee: New England Deaconess Hospital Corporation
    Inventors: Ronald R. Salem, Peter Thomas, Glenn Steele
  • Marker for colorectal carcinoma and methods of detecting the same
    Patent number: 4921789
    Abstract: A new marker for colorectal carcinoma has been discovered which is a glycoprotein having a molecular weight of approximately 160,000 daltons. Assay methods which can identify this marker are useful indetecting, diagnosing, and monitoring colorectal carcinoma, and in particular, carcinoma of the undifferentiated variety which heretofor were not readily detectible. For example, an assay which utilizes an antibody reacting to this glycoprotein marker is useful in a screening method for the detection and monitoring of colorectal carcinoma cells. Such an antibody can be included as part of a kit for screening a patient for colorectal carcinoma.
    Type: Grant
    Filed: April 20, 1988
    Date of Patent: May 1, 1990
    Assignee: New England Deaconess Hospital Corporation
    Inventors: Ronald R. Salem, Peter Thomas, Glenn Steele
  • Monoclonal antibody for colorectal carcinoma
    Patent number: 4892933
    Abstract: A monoclonal antibody raised to colorectal carcinoma, and a hybridoma which elicits the antibody, have been produced. This antibody, ND4 has been discovered to react with a new tumor marker, a glycoprotein of approximately 160 kD found on the surface of undifferentiated colorectal carcinoma cells; it does not cross-react with other known tumor markers. It is useful for detecting and monitoring colorectal carcinoma.
    Type: Grant
    Filed: April 20, 1988
    Date of Patent: January 9, 1990
    Assignees: New England Deaconess Hospital Corporation, Mallory Institute of Pathology Foundation
    Inventors: Ronald R. Salem, Peter Thomas, Norman Zamcheck, Glenn Steele